Alzheimer's disease (AD) is one of the most common multifactorial diseases, including a
range of abnormal cellular/molecular processes occurring in different regions of the brain …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
abnormal accumulation of extracellular amyloid beta senile plaques and intracellular …

Alzheimer's disease (AD) is the most common neurodegenerative disease in the developed
world. The increasing life expectancy in the last years has led to an increase in the …

Alzheimer's disease (AD) is one type of neurodegenerative diseases, which is prevalent in
the elderly. Beta-amyloid (Aβ) plaques and phosphorylated tau-induced neurofibrillary …

Alzheimer's disease (AD) is a multifaceted disorder, characterized by the failure of memory
and dementia. AD affects mostly elder above 65 years of age and is confirmed by post …

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges provides a
thorough overview of the latest advances toward the development of therapeutics for …

Alzheimer's disease (AD) is a devastating neurodegenerative disorder, with a rapidly
increasing worldwide prevalence. Although no cure for AD has yet been found, substantial …

It is now almost a century ago that Alois Alzheimer first presented his results in public. Main
characteristics of Alzheimer's disease (AD) are massive cerebral accumulation of amyloid …

Alzheimer's disease (AD) is a neurodegenerative disease that robs the minds of our elderly
population. Approximately one in every eight adults over the age of 65 and nearly half of …

Novel agents addressing non-amyloid, non-tau targets in Alzheimer's Disease (AD)
comprise 70% of the AD drug development pipeline of agents currently in clinical trials. Most …